🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study was designed to evaluate the antibody response to a Menactra® bo...
Status
Completed
Location
Multiple Locations
Start Date
2004-02
Trial ID
NCT00777790
This study will be conducted among children in Saudi Arabia who previously ...
Status
Completed
Location
Multiple Locations
Start Date
2007-09
Trial ID
NCT00539032
The study investigated safety profile and the antibody responses to an expe...
Status
Completed
Location
Multiple Locations
Start Date
2003-08
Trial ID
NCT00771849
The purpose of the study was to evaluate the immunogenicity and describe th...
Status
Completed
Location
Investigational Site
Start Date
2017-02-17
Trial ID
NCT03077438
The purpose of this trial is to describe the safety and antibody response t...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01442675
Primary objective is to evaluate the immune response to vaccination with te...
Status
Completed
Location
Research Site
Start Date
2015-02-28
Trial ID
NCT02097849
The aim of this study was to collect further information regarding an incre...
Status
Completed
Location
Multiple Locations
Start Date
2015-10-20
Trial ID
NCT02591290
Treatments Being Tested
The purpose of this study was to compare the immunogenicity and describe th...
Status
Completed
Location
Birmingham Pediatric Associates Site Number : 8400026
Start Date
2018-04-25
Trial ID
NCT03537508
The purpose of this study is to assess the immunogenicity and safety of Men...
Status
Completed
Location
Multiple Locations
Start Date
2013-06-25
Trial ID
NCT01890759
Treatments Being Tested
The purpose of the study is to characterize the immunogenicity \& safety of...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-02-13
Trial ID
NCT00614614